Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. [electronic resource] by
- Amengual, Jennifer E
- Lichtenstein, Renee
- Lue, Jennifer
- Sawas, Ahmed
- Deng, Changchun
- Lichtenstein, Emily
- Khan, Karen
- Atkins, Laine
- Rada, Aishling
- Kim, Hye A
- Chiuzan, Codruta
- Kalac, Matko
- Marchi, Enrica
- Falchi, Lorenzo
- Francescone, Mark A
- Schwartz, Lawrence
- Cremers, Serge
- O'Connor, Owen A
Producer: 20190513
In:
Blood vol. 131
Availability: No items available.
|
|
7.
|
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial. [electronic resource] by
- O'Connor, Owen A
- Lue, Jennifer K
- Sawas, Ahmed
- Amengual, Jennifer E
- Deng, Changchun
- Kalac, Matko
- Falchi, Lorenzo
- Marchi, Enrica
- Turenne, Ithamar
- Lichtenstein, Renee
- Rojas, Celeste
- Francescone, Mark
- Schwartz, Lawrence
- Cheng, Bin
- Savage, Kerry J
- Villa, Diego
- Crump, Michael
- Prica, Anca
- Kukreti, Vishal
- Cremers, Serge
- Connors, Joseph M
- Kuruvilla, John
Producer: 20190125
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
8.
|
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study. [electronic resource] by
- O'Connor, Owen A
- Falchi, Lorenzo
- Lue, Jennifer K
- Marchi, Enrica
- Kinahan, Cristina
- Sawas, Ahmed
- Deng, Changchun
- Montanari, Francesca
- Amengual, Jennifer E
- Kim, Hye A
- Rada, Aishling M
- Khan, Karen
- Jacob, Alice T
- Malanga, Michelle
- Francescone, Mark M
- Nandakumar, Renu
- Soderquist, Craig R
- Park, David C
- Bhagat, Govind
- Cheng, Bin
- Risueño, Alberto
- Menezes, Daniel
- Shustov, Andrei R
- Sokol, Lubomir
- Scotto, Luigi
Producer: 20200217
In:
Blood vol. 134
Availability: No items available.
|